JamesWLeeMD

Hematology • Moorestown, NJ

Hematologic Oncology

Physician

Join to view full profile

Dr. Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Lee's full profile

Already have an account?

Office
350 Young Ave
Ste 200
Moorestown, NJ 08057
Phone+1 609-702-1900

Fax+1 609-702-8456
Is this information wrong?

Education & Training

National Institutes of Health Clinical CenterFellowship, Infectious Disease, 1989 - 1993
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1986 - 1989
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1983 - 1986
Weill Cornell MedicineClass of 1983

Certifications & Licensure

NY State Medical License 2021 - 2026
NJ State Medical License 2001 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2013

Clinical Trials

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer Start of enrollment: 2008 Jan 01
Completed
Phase 2
Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer Start of enrollment: 2010 Jan 18
Completed
Phase 2
PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations Start of enrollment: 2010 Feb 01
Completed
Phase 2
Fludarabine, Velcade and Rituximab for Relapsed or Refractory Follicular Non-Hodgkin Lymphoma Start of enrollment: 2010 Oct 01
Terminated
Phase 2
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Jul 08
Completed
Join now to see all

Publications & Presentations

PubMed

Demonstration of horizontal gene transfer from genetically engineered Thermosynechococcus elongatus BP1 to wild-type E. coli DH5α.
Nguyen, T. H.,Barnes, C. L.,Agola, J. P.,Sherazi, S.,Greene, L. H.,Lee, J. W.> ;Gene. 2019 Apr 03
Comparative analysis of pinewood, peanut shell, and bamboo biomass derived biochars produced via hydrothermal conversion and pyrolysis.
Huff, M. D.,Kumar, S.,Lee, J. W.> ;J. Environ. Manage.. 2014 Sep 06

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Virtua Mount Holly HospitalMount Holly, New Jersey